The report titled “Europe
POCT Devices Market Outlook to 2022 - by Geography (Western Europe &
Eastern Europe), by Product (Blood Glucose POCT, Infectious POCT, Cardiac POCT,
Rapid Coagulation POCT, Blood Gas & Electrolytes POCT, Hematology POCT,
Pregnancy POCT, Urinalysis POCT, Cholesterol POCT, Fecal Occult POCT, Hb1Ac
POCT & Drugs of Abuse POCT), by Customer Segments (Hospitals & Clinics,
Diagnostics Labs & Primary Care Units and Homecare & Patients)”
provides a comprehensive analysis
of Europe POCT devices market evolution and overview, market ecosystem, market
nature, value chain & entity analysis (OEM’s, C&F agents, distributors,
retailers & customers), market size,
and market segments by Geography (Western Europe & Eastern Europe),
by Product (Blood Glucose POCT, Infectious POCT, Cardiac POCT, Rapid
Coagulation POCT, Blood Gas & Electrolytes POCT, Hematology POCT, Pregnancy
POCT, Urinalysis POCT, Cholesterol POCT, Fecal Occult POCT, Hb1Ac POCT &
Drugs of Abuse POCT), by Customer Segments (Hospitals & Clinics,
Diagnostics Labs & Primary Care Units and Homecare & Patients) and by
Instruments and Consumables. Competition landscape, competition nature, major
competition parameters and market share of major companies along with company
profiles of Alere, Roche Holding AG, Siemens Healthineers, Becton Dickinson,
Sysmex Corporation, EKF Diagnostics Holding, PTS Diagnostics, Werfen, Danaher
Corporation, A. Menarini Diagnostics, Trinity Biotech, FujiFilm and others have been profoundly covered in the
report. The report underscores prevailing government rules and regulation along
with analyst recommendation to highlight the major opportunities and cautions.
The report is useful for POCT Devices manufacturers, distributors,
retailers, potential entrants and other stakeholders to align their market
centric strategies according to ongoing and expected trends in the future.
Europe POCT Devices Market Size and Overview
Market Size: Europe POCT Devices Market has grown registering a robust
CAGR of close to 8% during the review period. Currently, the market is in
growth stage with high potential of future expansion in both developed and
developing countries of the region. Various factors supporting growth include high
incidence of chronic diseases, rising health awareness, medical advancement in
POCT sector, advancement in medical knowledge and R&D work, unease
associated with laboratory testing methods and new companies venturing the
market. Increase in urban population especially in the metro-cities which has
been the largest end-user segment of the market and higher spending on R&D
activities by the companies has led to the rise in number of point of care
testing devices & customer interest. A substantial increase in awareness
amongst population in cities & smaller towns has provided major thrust to
this market. In parallel, growth & popularity of pregnancy& blood
glucose POCT and advancement in technologies have given rise to new and
improved devices. Advent of deadly infectious and cardiac diseases has led
people to use these devices for quick detection. However, the market has been
flooded with “fake” products, found all throughout the value chain.
Market Segmentation
By
Geography: Western Europe
has led the overall European scenario in terms of sales of POCT devices in 2017.
Advanced medical infrastructure, higher level of disposable income of people,
higher awareness and spending on healthcare, presence of well established
manufacturers and government support has enabled countries such as the Germany,
Italy and UK to lead the overall European landscape in terms of both, sales and
demand in the review period.
By
Product: Blood Glucose
POCT devices led the market with highest sales revenue in 2017. The devices are used on routine basis
to monitor glucose levels for people at home or for patients under tight
glycemic control requirements. This segment was followed by Infectious,
Cardiac, Rapid Coagulation, Blood Gas and Electrolytes, Hematology, Pregnancy
POCT, Urinalysis POCT, Cholesterol Fecal Occult, Drugs of Abuse and Hb1Ac POCT
devices respectively.
By
Customer Segment: Hospitals
and Clinics have been the largest customers of POCT devices in Europe in 2017. The entity uses these devices for diagnostics,
treatment, monitoring and rapid testing. The tests carried out consists of TB,
HIV, Malaria, Syphilis, Dengue, Strep A,
HBV, C Diff, CD, 4, HCV, MRSA, Flu, UTI, Viral and others. Diagnostic labs and
primary care units constitute for second largest share in the market. Home care
and patients occupied lowest share owing to low volume sales and low
replacement demand. Major motive to buy a POCT device for home patients is self
assessment & referral and cost reduction.
By
Instruments and Consumables: Instruments
comprise of an apparatus or a machine that is used in the diagnosis of an
illness or disease, or for detecting, measuring, restoring, correcting or
modifying the structure or function of the body for some health purpose.
Consumables primarily comprise of strip based instruments such as
Electrochemical or reflectance strip-based glucose meters and INR analyzers. HbA1c, Pregnancy, Cholesterol and Drug of Abuse POCT devices
utilize consumables in large scale for diagnostics.
Competitive Landscape
Competition in the market
has been concentrated among 6 major & 10-15 smaller companies in 2017. These
include Radiometer, Werfen, Siemens, Roche, Nova, Alere and others. Major
competition is being driven through new product launches, innovation and
marketing initiatives. Products are being manufactured domestically as well as
imported.
Future Outlook and
Tailwind
Market has been anticipated to
showcase a substantial growth at a CAGR of close to 6% during the forecast
period. Increase in the number of new entrants in the market, larger product
acceptance, new product launches, expanding distribution channels of existing
players and higher marketing expenditure done by the companies are expected to
be tailwind for future growth.
For more information on the research report, refer to below link:
Related
Reports:-
https://www.kenresearch.com/healthcare/medical-devices/vietnam-medical-devices-market/143604-91.html
+91-9015378249